triamcinolone has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cessna, CT; Hjelmeland, LM; Modjtahedi, SP; Morse, LS; Smit-McBride, Z; Telander, DG | 1 |
| Baker, T; Hall, ED; Riker, WF | 1 |
2 other study(ies) available for triamcinolone and Nerve Degeneration
| Article | Year |
|---|---|
In vivo gene expression profiling of retina postintravitreal injections of dexamethasone and triamcinolone at clinically relevant time points for patient care.
Topics: Animals; Dexamethasone; Gene Expression Profiling; Gene Expression Regulation; Genomics; Glucocorticoids; Humans; Intravitreal Injections; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Real-Time Polymerase Chain Reaction; Retina; Signal Transduction; Time Factors; Triamcinolone | 2011 |
Beneficial action of glucocorticoid treatment on neuromuscular transmission during early motor nerve degeneration.
Topics: Animals; Cats; Female; Male; Motor Neurons; Muscle Contraction; Nerve Block; Nerve Degeneration; Neuromuscular Junction; Protein-Lysine 6-Oxidase; Sciatic Nerve; Synaptic Transmission; Triamcinolone; Tubocurarine | 1983 |